Regenerative repair of Pifithrin-[alpha] in cerebral ischemia via VEGF dependent manner

• Published in: Scientific reports Vol. 6; p. 26295
• Main Authors: Zhang, Ping, Lei, Xuhui, Sun, Ying, Zhang, Haitao, Chang, Liang, Li, Chenlong, Liu, Daming, Bhatta, Nishant, Zhang, Zhiren, Jiang, Chuanlu
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group 01.05.2016
• Subjects: Angiogenesis; Ischemia; Neurogenesis; Rodents; Signal transduction; Stroke; Vascular endothelial growth factor
• ISSN: 2045-2322
• DOI: 10.1038/srep26295

Promoting regenerative repair, including neurogenesis and angiogenesis, may provide a new therapeutic strategy for treatment of stroke. P53, a well-documented transcription factor, has been reported to be involved in cerebral ischemia and also serves as an important regulator of vascular endothelial growth factor (VEGF). However, the role of p53 in endogenous regenerative repair after brain ischemia is poorly understood. In this study, we investigated the effects of PFT-α, a specific p53 inhibitor on neurogenesis and angiogenesis improvement and associated signal pathways in rats impaired by cerebral artery occlusion (MCAo). PFT-α induced neuroprotection, reduced infarct volume and neurological functional impairment after ischemic stroke. More importantly, neurogenesis and angiogenesis were greatly enhanced by PFT-α, and accompanied by increased expression of VEGF. Moreover, we got consistent results in neural stem cells (NSCs) isolated from fetal rats. In contrast, application of the anti-VEGF neutralizing antibody (RB-222) partially reversed PFT-α-induced neuroprotection and rescued p53 expression. Noteworthily, inhibition of p53 after ischemic stroke in these rats improved their outcomes via promotion of regenerative repair. In conclusion, PFT-α could serve as a promising therapeutic strategy for ischemic stroke by promoting regenerative repair.